Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04759846
Status:
WITHDRAWN
Last Update Posted:
2023-02-21
First Post:
2020-12-21
Brief Title:
Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma
Sponsor:
Pierre Fabre Medicament
Organization:
Pierre Fabre Medicament
Organization Data
Organization:
Pierre Fabre Medicament
Class:
INDUSTRY
Study ID:
W00090GE101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pierre Fabre Medicament
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None